chr7-6005918-C-T
Variant summary
The NM_000535.7(PMS2):c.137G>A (p.Ser46Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant has a gnomAD grpmax filtering allele frequency (95% CI) of 0.00000072, indicating it is observed in the general population. Note: a gnomAD entry for this variant shows a statistical allele-bias signature, consistent with mosaic/somatic contamination (e.g. age-related clonal hematopoiesis) rather than true inherited population frequency — this frequency should not be read as evidence of a common, benign germline variant. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 7.54). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000552059: Experimental studies have shown that this missense change affects PMS2 function (PMID:24027009)." and additional evidence is available in ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.S46G: Uncertain_significance (ClinVar VariationId 525851, 1 star); p.S46R: Uncertain_significance (ClinVar VariationId 1771527, 1 star); p.S46= (synonymous): Likely_benign (ClinVar VariationId 1771525, 1 star) This exact variant is established as oncogenic in: CGI (Cancer Genome Interpreter). This exact variant is curated in the UniProt human variants database as Uncertain Significance.
Frequency
Consequence
NM_000535.7 missense
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Lynch syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- mismatch repair cancer syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- ovarian cancerInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Muir-Torre syndromeInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 12 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000552059: Experimental studies have shown that this missense change affects PMS2 function (PMID: 24027009).; SCV002013800: Published functional studies demonstrate a damaging effect: deficient mismatch repair activity (PMID: 24027009); SCV001351217: A functional study has shown that this variant protein causes significantly decreased mismatch repair activity in an in vitro assay (PMID: 24027009).; SCV002699807: "In an in vitro study, this alteration displayed less than 10% relative repair efficiency compared to the wild-type control, a level similar to the repair-deficient control (Drost M et al. Hum. Mutat. 2013 Nov; 34(11):1477-80)."; SCV004187643: Functional studies indicate this variant impacts protein function [PMID: 24027009]. | ||
| PM2Absent/extremely low in population databases | Very rare in gnomAD for AD/XL gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.00000072 — very rare for AD+AR gene (base 0.0001, raised to 0.000336 by highest known P/LP ClinVar AF 0.000336) — PM2 moderate. | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — moderate evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Moderate). | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000535.7. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
PMS2 | MANE Select | c.137G>A p.Ser46Asn | missense | Exon 2 of 15 | Prot: NP_000526.2 UniProt: | |
PMS2 | c.323G>A p.Ser108Asn | missense | Exon 3 of 16 | Prot: NP_001393795.1 UniProt: | ||
PMS2 | c.137G>A p.Ser46Asn | missense | Exon 2 of 15 | Prot: NP_001308943.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
PMS2 | TSL:1MANE Select | c.137G>A p.Ser46Asn | missense | Exon 2 of 15 | Prot: ENSP00000265849.7 UniProt: | |
PMS2 | TSL:1 | c.137G>A p.Ser46Asn | missense | Exon 2 of 11 | Prot: ENSP00000371758.4 UniProt: | |
PMS2 | TSL:1 | n.137G>A | non_coding_transcript_exon | Exon 2 of 13 | Prot: ENSP00000514464.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 4 sources | |||||
GnomAD3 genomes | Cov:33 | ||||
GnomAD2 exomes | AF: 0.00000814 | AC:2 | AN:245780 | ||
GnomAD4 exome Warning | AF: 0.00000206 | AC:3 | Hom:0 | AN:1458548 | Cov:31 |
GnomAD4 genome | Cov:33 | ||||
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 30 | |
AlphaMissense | Pathogenic | 0.96 | |
BayesDel_addAF | Pathogenic | 0.17 | D |
BayesDel_noAF | Uncertain | 0.020 | |
CADD | Pathogenic | 28 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Uncertain | 0.79 | D |
Eigen | Pathogenic | 1.0 | |
Eigen_PC | Pathogenic | 0.95 | |
FATHMM_MKL | Pathogenic | 0.98 | D |
FuncVEP CTI | Pathogenic | 1.0 | |
GPN-Star LLR | N/A | -5.8 | |
GPN-Star score | N/A | 5.8 | |
LIST_S2 | Pathogenic | 0.98 | D |
M_CAP | Pathogenic | 0.35 | D |
MetaRNN | Pathogenic | 0.98 | D |
MetaSVM | Pathogenic | 0.81 | D |
Mutation Taster | N/A | 1/99 | disease causing (ClinVar) |
MutationAssessor | Pathogenic | 4.3 | H |
PhyloP100 | Pathogenic | 7.5 | |
popEVE | Benign | -4.1 | |
PrimateAI | Uncertain | 0.70 | T |
PROVEAN | Uncertain | -2.7 | D |
REVEL | Pathogenic | 0.81 | |
Sift | Uncertain | 0.0020 | D |
Sift4G | Uncertain | 0.0020 | D |
Varity_R | N/A | 0.96 | |
VESM-3B | Benign | -15 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.